| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/25/1997 | US5614682 Sampling device for molten metals |
| 03/25/1997 | US5614670 Movable seismic pavement analyzer |
| 03/25/1997 | US5614662 Apparatus and method for measuring a paper surface roughness |
| 03/25/1997 | US5614655 Gas mixing device |
| 03/25/1997 | US5614630 Neurotransmitter release modulator |
| 03/25/1997 | US5614618 Origin of replication complex genes |
| 03/25/1997 | US5614610 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/25/1997 | US5614609 Serine threonine kinase receptor |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614419 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 03/25/1997 | US5614417 In presence of hydrocarbons, reaction product of sulfur monooxide and ozone |
| 03/25/1997 | US5614416 Aqueous calibrant fluid with reservoirs and charging |
| 03/25/1997 | US5614414 Liquid lipoprotein control |
| 03/25/1997 | US5614406 Kainate-binding human CNS receptors of the EAA2 family |
| 03/25/1997 | US5614404 Plasmid vector for insertion of human immunodeficiency virus dna sequences into a pox virus |
| 03/25/1997 | US5614402 5' nucleases derived from thermostable DNA polymerase |
| 03/25/1997 | US5614394 Immunizing mice, fusion of lymphocytes and myeloma cells |
| 03/25/1997 | US5614384 Hepatitis B virus surface proteins with reduced host carbohydrate content |
| 03/25/1997 | US5614372 Distiction between cancer and benign hyperplasia |
| 03/25/1997 | US5614371 Ri fusion antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof |
| 03/25/1997 | US5614370 Assay to identify human C5a antagonists and agonists |
| 03/25/1997 | US5614369 Endotoxin binding and neutralizing protein and uses thereof |
| 03/25/1997 | US5614368 Chromophoric reagents for incorporation of biotin or other haptens into macromolecules |
| 03/25/1997 | US5614367 Diagnostic test using chimeric antibodies |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614362 Nucleic acid hybridization assay for hepatitis B virus DNA |
| 03/25/1997 | US5614195 Coccidiosis poultry vaccine |
| 03/25/1997 | US5614067 Leaching device for electrolyzed silver |
| 03/25/1997 | US5613713 Arrangement for cleaning a container testing apparatus |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA2030381C Reagent and method of using same for the automatic flow cytometry determination of at least one leukocyte sub-population from total blood |
| 03/25/1997 | CA2004642C Process for the detection of compounds containing carbohydrate and a suitable reagent therefor |
| 03/25/1997 | CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof |
| 03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
| 03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/25/1997 | CA1339010C Oligonucleotide polymeric support system |
| 03/25/1997 | CA1339006C Self-contained multi-immunoassay diagnostic system |
| 03/25/1997 | CA1339005C Method of assay |
| 03/23/1997 | CA2185856A1 Peptide ligands which bind to von willebrand factor |
| 03/20/1997 | WO1997010510A1 Automatic laboratory machine |
| 03/20/1997 | WO1997010509A1 Complex-bound inhibitors of metabolic enzymes capable of being activated, useful as molecular markers for diagnostic and therapy monitoring purposes |
| 03/20/1997 | WO1997010508A1 Method for the diagnosis of coeliac disease |
| 03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/20/1997 | WO1997010506A1 Optical apparatus for performing an immunoassay |
| 03/20/1997 | WO1997010505A1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿ |
| 03/20/1997 | WO1997010504A1 Antibody radioimmunoassays for human propeptide/prohormone convertases pc1/3 and pc2 |
| 03/20/1997 | WO1997010503A1 Method for screening for prostate cancer by measuring apolipoprotein d levels in body fluid |
| 03/20/1997 | WO1997010502A1 A high throughput assay using fusion proteins |
| 03/20/1997 | WO1997010501A1 Determination of sodium sulfide and sulfidity in green liquors and smelt solutions |
| 03/20/1997 | WO1997010500A1 Apparatus for testing items of metal such as jewellery |
| 03/20/1997 | WO1997010494A1 Fluorescence detector |
| 03/20/1997 | WO1997010493A1 METHOD FOR MEASURING NITROSYL (FeII)-HEMOGLOBIN |
| 03/20/1997 | WO1997010492A2 Process for determining and evaluating melt flow index values |
| 03/20/1997 | WO1997010384A2 Process and arrangement for monitoring cellulose digestion |
| 03/20/1997 | WO1997010365A1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 03/20/1997 | WO1997010364A1 Continuous amplification reaction |
| 03/20/1997 | WO1997010358A1 Screening methods for the identification of novel antibiotics |
| 03/20/1997 | WO1997010357A1 A method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism and an associated apparatus |
| 03/20/1997 | WO1997010333A1 Novel proteins remarkably expressed in liver cancer, genes encoding the same, antibodies against the same, and method for detecting the expression of the same |
| 03/20/1997 | WO1997010274A1 Reduced solvent process for preparation of aqueous polyurethane dispersions with improved heat and solvent resistance |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010253A1 A high throughput assay using fusion proteins |
| 03/20/1997 | WO1997010250A1 Purification of a novel glycophospholipid |
| 03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | WO1997010056A2 Device and method for dna amplification and assay |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009996A1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1997009925A2 Method for early detection of ovarian cancer |
| 03/20/1997 | WO1997009886A1 Methods and compositions for prevention and treatment of clostridium difficile-associated diseases |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof |
| 03/20/1997 | DE19544127C1 Suspended particle micro-manipulation |
| 03/20/1997 | DE19535571A1 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten Pharmaceutical combination preparations and their use for the treatment of hemodialysis patients |
| 03/20/1997 | DE19535569A1 Determination of damaged area of surface of stressed component |
| 03/20/1997 | DE19534557A1 Determination of carbon dioxide content in gas by metal-oxide sensors |
| 03/20/1997 | DE19534195A1 Agent for enhancing binding properties of auto-antibodies |
| 03/20/1997 | DE19534046A1 Radio-iodinating oligo-nucleotide, protein or peptide |
| 03/20/1997 | DE19533817A1 Komplex-gebundene Hemmstoffe aktivierbarer Stoffwechselenzyme als molekulare Marker zur Diagnostik und Therapieüberwachung Complex-bound inhibitors activatable metabolic enzymes as molecular markers for diagnosis and therapy monitoring |
| 03/20/1997 | CA2232173A1 Screening methods for the identification of novel antibiotics |
| 03/20/1997 | CA2232171A1 Process and arrangement for monitoring the cooking of pulp |
| 03/20/1997 | CA2232050A1 Method for measuring nitrosyl (feii)-hemoglobin |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232047A1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231528A1 Method for the diagnosis of coeliac disease |
| 03/20/1997 | CA2231385A1 A high throughput assay using fusion proteins |
| 03/20/1997 | CA2231381A1 Purification of a novel glycophospholipid |
| 03/20/1997 | CA2231354A1 Complex-bound inhibitors of metabolic enzymes capable of being activated, useful as molecular markers for diagnostic and therapy monitoring purposes |
| 03/20/1997 | CA2231330A1 A high throughput assay using fusion proteins |
| 03/20/1997 | CA2231329A1 Fluorescence detector |
| 03/20/1997 | CA2229427A1 Method for early detection of ovarian cancer |
| 03/20/1997 | CA2229059A1 A method for determining the antimicrobial agent sensitivity of a nonparaffinophilic microorganism and an associated apparatus |